Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Seeman

Showing results (171-180 of 325) with videos related to

Pageof 33
Sort By:
Annals of the New York Academy of Sciences|December 10, 1999
Charcot-Marie-Tooth 1A: heterozygous T118M mutation over a CMT1A duplication has no influence on the phenotypeP Seeman, R Mazanec, T Marikova, et al.
Brain Research. Molecular Brain Research|November 12, 2002
Schizophrenia and Nogo: elevated mRNA in cortex, and high prevalence of a homozygous CAA insertG Novak, D Kim, P Seeman, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1978
Multiple receptors for brain dopamineM Titeler, P Weinreich, D Sinclair, et al.
Annals of Neurology|December 1, 1978
The L-dopa on-off effect in Parkinson disease: treatment by transient drug withdrawal and dopamine receptor resensitizationL Direnfeld, L Spero, J Marotta, et al.
European Journal of Pharmacology|December 5, 1980
High-affinity binding of [3H]mianserin to rat cerebral cortexA Dumbrille-Ross, S W Tang, P Seeman
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 1, 1982
Striatal binding of 2-amino-6,7-[3H]dihydroxy-1,2,3,4-tetrahydronaphthalene to two dopaminergic sites distinguished by their low and high affinity for neurolepticsS J List, K A Wreggett, P Seeman
Canadian Journal of Physiology and Pharmacology|November 1, 1981
Multiple binding sites for [3H]clonidine and [3H]WB-4101 in rat brainP Weinreich, A Chiu, J Warsh, et al.
Biochemical and Biophysical Research Communications|April 29, 1988
Dopamine D1 receptors with enhanced agonist affinity and reduced antagonist affinity revealed by chemical modificationN H Bzowej, H B Niznik, P Seeman
Canadian Journal of Physiology and Pharmacology|June 1, 1974
A new prolonged-acting type of chlorpromazine: behavioral effects and prolonged actions on nerve membranesP Seeman, H Machleidt, J Kähling, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1976
Dopamine receptors in human and calf brains, using [3H]apomorphine and an antipsychotic drugP Seeman, M Chau-Wong, J Tedesco, et al.
Pageof 33

Showing results (171-180 of 325) with videos related to

Sort By:
Pageof 33
Annals of the New York Academy of Sciences|December 10, 1999
Charcot-Marie-Tooth 1A: heterozygous T118M mutation over a CMT1A duplication has no influence on the phenotypeP Seeman, R Mazanec, T Marikova, et al.
Brain Research. Molecular Brain Research|November 12, 2002
Schizophrenia and Nogo: elevated mRNA in cortex, and high prevalence of a homozygous CAA insertG Novak, D Kim, P Seeman, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1978
Multiple receptors for brain dopamineM Titeler, P Weinreich, D Sinclair, et al.
Annals of Neurology|December 1, 1978
The L-dopa on-off effect in Parkinson disease: treatment by transient drug withdrawal and dopamine receptor resensitizationL Direnfeld, L Spero, J Marotta, et al.
European Journal of Pharmacology|December 5, 1980
High-affinity binding of [3H]mianserin to rat cerebral cortexA Dumbrille-Ross, S W Tang, P Seeman
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 1, 1982
Striatal binding of 2-amino-6,7-[3H]dihydroxy-1,2,3,4-tetrahydronaphthalene to two dopaminergic sites distinguished by their low and high affinity for neurolepticsS J List, K A Wreggett, P Seeman
Canadian Journal of Physiology and Pharmacology|November 1, 1981
Multiple binding sites for [3H]clonidine and [3H]WB-4101 in rat brainP Weinreich, A Chiu, J Warsh, et al.
Biochemical and Biophysical Research Communications|April 29, 1988
Dopamine D1 receptors with enhanced agonist affinity and reduced antagonist affinity revealed by chemical modificationN H Bzowej, H B Niznik, P Seeman
Canadian Journal of Physiology and Pharmacology|June 1, 1974
A new prolonged-acting type of chlorpromazine: behavioral effects and prolonged actions on nerve membranesP Seeman, H Machleidt, J Kähling, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1976
Dopamine receptors in human and calf brains, using [3H]apomorphine and an antipsychotic drugP Seeman, M Chau-Wong, J Tedesco, et al.
Pageof 33